Simmbion Competitors and Similar CompaniesClear all
Simmbion's competitors and similar companies include Biosynex, Exagen, Truvian Sciences and Biocrates Life Sciences.
 Simmbion Simmbion is a company specializing in the development of symbiotic synthetic cells for the treatment of chronic diseases. |  Biosynex The BIOSYNEX Group is one of the most significant European manufacturers and provider of rapid membrane tests in the in-vitro diagnostic market. |  Exagen Exagen is a biotechnology company engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. |  Truvian Sciences Truvian Sciences is a company that develops medical technology designed to provide blood diagnostics and testing. |  Biocrates Life Sciences Biocrates Life Sciences is a developer of targeted metabolic phenotyping solutions. | |
Founding Date | Founding Date 2017 | Founding Date 2005 | Founding Date 2002 | Founding Date 2015 | Founding Date 2002 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Baltimore, US HQ | Locations Illkirch-Graffenstaden, FR HQ | Locations Vista, US HQ | Locations San Diego, US HQ | Locations Innsbruck, AT HQ |
Employees | Employees 167% decrease | Employees 476 | Employees 144 | Employees 1204% decrease | Employees 593% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 35.7 m | Valuation ($) 45 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €101.2m (FY, 2024) | Revenue (est.) $66.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €43.7m (FY, 2024) | Cost of goods $27.8m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €80.2m (FY, 2024) | Gross profit $38.8m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income (€43.3m) (FY, 2024) | Net income ($20m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 105m (over 5 years ago) | Latest funding round $ 956k (over 10 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 49.6m | Total funding raised $ 151.3m | Total funding raised $ 14.2m |
For sources of this data, please see the company profile
View Company Profiles
Biosynex
HQ
Illkirch-Graffenstaden, FR
Employees
476
The BIOSYNEX Group is one of the most significant European manufacturers and provider of rapid membrane tests in the in-vitro diagnostic market.
View companyExagen
HQ
Vista, US
Employees
144
Exagen is a biotechnology company engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention.
View companyTruvian Sciences
HQ
San Diego, US
Employees
120↓ 4% decrease
Truvian Sciences is a company that develops medical technology designed to provide blood diagnostics and testing.
View companyBiocrates Life Sciences
HQ
Innsbruck, AT
Employees
59↓ 3% decrease
Biocrates Life Sciences is a developer of targeted metabolic phenotyping solutions.
View company